Esophageal varices
Conditions
Interventions
Group 1:Intravariceal injection of sclerosant with bc-EIS
Group 2:Intravariceal injection of sclerosant with EIS alone
Group 3:EVL alone
Sponsors
The First Affiliated Hospital of Anhui Medical University
Eligibility
Sex/Gender
All
Age
18 Years to 80 Years
Inclusion criteria
Inclusion criteria: 1. Cirrhotic patients with endoscopic presentation of esophageal varices; 2. Active esophageal variceal bleeding(EVB) or previous episodes of EVB; 3. Aged 18 to 80 years old.
Exclusion criteria
Exclusion criteria: 1. Poor overall health status, including multiorgan failure, hepatic encephalopathy grade III and IV, and malignancies other than hepatocellular carcinoma (HCC) meeting the Milan criteria, etc; 2. Previous history of EIS, EVL, TIPS treatment or liver transplantation; 3. Known allergy to the sclerosant used in the study (Lauromacrogol; Tianyu, Xian, China).
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| The eradication of EVs; | — |
Secondary
| Measure | Time frame |
|---|---|
| Recurrence of EVs;Number of sessions required for the eradcarion of EVs;Postoperative rebleeding rate;Postoperative procedure-related complications;Hemostasis of EVB; | — |
Countries
China
Contacts
Public ContactKong Derun
The First Affiliated Hospital of Anhui Medical University
Outcome results
None listed